| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | $254.65 | -0% | $449.91B | 107.4 | -13.3% | 2.6% | Healthcare | 35.7% | 9.5% | ||
| 2 | Novo Nordisk A/S | $49.64 | 0.8% | $220.59B | 14.1 | 16.8% | 3.6% | Healthcare | -28.4% | 8.1% | ||
| 3 | Amgen Inc. | $368.10 | 0.5% | $198.66B | 25.9 | 31.1% | 2.6% | Healthcare | 25.7% | 9.1% | ||
| 4 | Gilead Sciences, Inc. | $136.36 | 5.2% | $169.3B | 20.1 | 54.5% | 2.3% | Healthcare | 22% | 3.5% | ||
| 5 | Biogen Inc. | $205.70 | -1.3% | $30.37B | 23.3 | -7.8% | — | Healthcare | 58.1% | 0.4% | ||
| 6 | Scilex Holding Company | $9.93 | 23% | $84M | -0.3 | -148.5% | — | Healthcare | 58.9% | -33.2% |